Depression is common in elderly people
Depression in older people is common. It often goes unrecognised by both patients and doctors, is frequently under-treated,
and can account for greater levels of disability than physical illness.1
Medical conditions associated with depression
- Viral infection
- Certain endocrine disorders (e.g. thyroid disorders, Cushing's syndrome, adrenal insufficiency, hyperparathyroidism)
- Cerebrovascular disease (e.g. stroke, vascular dementia)
- Parkinson's disease
- Myocardial infarction
- Metabolic disorder (e.g. B12 or folate deficiency, malnutrition)
Medicines associated with depressed mood
- Benzodiazepines or other central nervous system depressants
- Beta-blockers (especially lipid soluble e.g. propranolol)
- Anti-parkinsonian drugs
List adapted from Alexopoulos3 and Prodigy4
Other causes of low mood may be even more common, can be more difficult to diagnose, and can still cause significant
Depression in elderly people is a significant cause of disability
Depression is a significant cause of disability, causing suffering, family disruption and possibly worsening outcomes
of other co-morbidities. The New Zealand Mental Health Survey established that mood related disability is greater than
disability related to chronic conditions.1 The causes of depression in older people may be different from younger
people. Age-related disorders increase the vulnerability to depression; cancer, stroke, myocardial infarction and Parkinson's
disease are all associated with depression in elderly people.3 Various medications can cause a depressed mood,
including, beta-blockers, corticosteroids and anti-parkinsonian drugs.
Depression in this population can be harder to treat due to increased clinical complexity.5
Depression is under recognised and under treated in elderly people
There are complex reasons for under-recognition of depression in elderly people. Barriers to diagnosis may include time
constraints, other co-morbidities which complicate diagnosis and reluctance to discuss emotional problems. The stigma
associated with depression may prevent elderly people seeking medical help and older people may also perceive that a low
mood is normal.
Some studies report that less than 30% of elderly depressed patients receive adequate antidepressant therapy.6 Antidepressants
prescribed at insufficient doses and for an inadequate length of time contribute to treatment failure. Adherence is a
major factor influencing the success of treatment and is often complicated by complex medication regimens, disability
and cognitive impairment.3,4
Diagnosis of depression
Symptoms of depression in elderly people can often be mistakenly attributed to "normal" old age. On the other hand some
symptoms frequently associated with depression may be caused by other problems. For example, pain may contribute to a
decreased interest or pleasure in activities, denture related eating difficulties can contribute to weight loss and many
elderly people have disruptions in sleep patterns that may not be related to depression.
Tools such as the Geriatric Depression Scale (click to open)
have been specifically developed for older populations to address
these issues and give more weight to moodrelated symptoms.7
Elderly people respond as well to antidepressants as younger people
Once a diagnosis is made it is important to treat depression in elderly people adequately. This includes using the correct
antidepressant at adequate doses for a sufficient treatment period. Maximal response may not be reached for up to 8-10
weeks and uptitration can continue for longer periods. Evidence suggests that depressed elderly people respond as well
to antidepressants as younger people with depression.3
SSRIs can be used initially for most depressed older people
SSRIs are generally considered first line in depressed older people. SSRIs have a similar efficacy to TCA antidepressants
but SSRIs may be better tolerated by elderly people.8
Starting with a low dose and increasing gradually reduces the risk of adverse effects. Although initial doses of SSRIs
should be lower in older people, maintenance doses may be similar to those used in younger people.3
Fluoxetine has a long half life and can take three to four weeks to reach steady state which can complicate dose titration.
Paroxetine and citalopram have shorter half lives but withdrawal reactions are a disadvantage which requires tapering
on discontinuation. Citalopram would be a suitable choice because it has less potential for interactions, which may be
a particular concern in elderly people already on complex regimens.
It is important to trial any antidepressant for four to six weeks after reaching the recommended dose, before it is
determined ineffective and another drug is tried.
TCAs used if unresponsive or intolerant to SSRIs
Tricyclic antidepressants may be considered in those who do not respond or who are not tolerant of SSRIs. Again initial
doses should be low and increased gradually. TCAs may be more appropriate initially if a concurrent medical condition
exists such as urinary incontinence, where a TCA may be substituted for oxybutynin.
Nortriptyline is a suitable choice of TCA because it has less sedative and anticholinergic effects, and may cause less
orthostatic hypotension. It is safer to use in elderly people than other TCAs, such as amitriptyline, dothiepin or doxepin.3
Table 1 compares these two different classes of antidepressant.
|Table 1: Comparison of SSRIs and TCAs
Common - nausea, vomiting, diarrhoea, dizziness, drowsiness, insomnia, agitation, and anxiety. Often
these can be prominent in the initial phase of treatment but may improve with time. Increased risk of falls.
Uncommon - hyponatraemia. Symptoms are usually non-specific and include anorexia, nausea, fatigue, lethargy, and
confusion. If patients develop any of these symptoms hyponatraemia should be considered and electrolyte levels should
Common - Anticholinergic side effects which include dry mouth, blurred vision, urinary
retention, constipation, and sedation. Increased risk of falls and associated fractures in elderly people.
Uncommon - cardiotoxicity. This is an important consideration in elderly people with co-morbid cardiac disease.
Fluoxetine and paroxetine inhibit the hepatic cytochrome P450 isoenzymes and interact with other drugs
metabolised by these enzymes such as TCAs.
Citalopram has a relatively low risk of interactions in comparison.
SSRIs may increase the risk of bleeding and the risk may be further increased by concurrent use of other medicines
that increase bleeding risk such as warfarin, NSAIDs or aspirin.
|Increased anticholinergic effects if other anticholinergic drugs are taken in combination.
These include other antidepressants, some antiparkinsonian drugs, antihistamines, antipsychotics, and antiemetics.
||Withdrawal symptoms may occur if antidepressants are discontinued abruptly. Doses should
be tapered over at least four weeks.6
Co-morbid cardiac disease
History of epilepsy
TCAs are very toxic in overdose
Other pharmacological treatment options
The reversible monoamine oxidase inhibitor (MAOI), moclobemide, can be used but there is limited evidence of its efficacy
in elderly people.6
Irreversible MAOIs should only be considered in those who have had a previous good response to them or who are intolerant
of other agents. They have many interactions, including food interactions, making them difficult to use safely.
Elderly people with treatment resistant depression can use venlafaxine but special consideration should be given to
the potential for adverse cardiovascular effects (see BPJ 1 - Venlafaxine).
Antidepressants and co-morbidities
Depression with a mental or physical co-morbidity is common in elderly people and is likely to respond to antidepressant
treatment. Prescribers may have concerns about interaction of the treatment with the co-morbid condition.
- Cardiac disease - TCAs may induce arrhythmia and can cause hypotension. Caution is required with venlafaxine. SSRIs
appear to be generally safer but this has not yet been subject to large-scale trials.
- Epilepsy - SSRIs and TCAs may lower seizure threshold; use low doses and titrate slowly.
- Glaucoma - TCAs can precipitate acute narrow-angle glaucoma, SSRIs are less implicated.
- Prostatism - TCAs may lead to urinary obstruction for men with prostatism.
- Parkinson's disease - SSRIs and TCAs may be used although caution is required with TCAs because of their side effect
- Dementia - Depression can be treated in people with dementia as it can in other older people with depression. Depression
responds to antidepressants even in the presence of dementia.4
Falls and depression go hand in hand
Depression is a significant risk factor for falls and falls predispose development of depression. Drug treatment for
depression is also an independent risk factor for falls, SSRIs are no safer than TCAs.9
The exact reason for this close association between falls and depression is not known. Whether depression results in
decreased activity, deconditioning and physical frailty and subsequent falls, or whether there is a central mechanism
associated with depression that causes falls, is not known. Some people with depression have an abnormal gait pattern.10,11
Non-pharmacological treatment options
Psychological therapy should be considered in all elderly patients with depression. Psychological and pharmacological
therapies initiated together are ideal for moderate depression although either treatment alone may be considered in mild
depression. Some suitable psychological therapies for elderly people with depression are; cognitive therapy, supportive
psychotherapy, problem-solving therapy and interpersonal therapy.
Electroconvulsive therapy can also be used in severe, unresponsive depression although there are risks associated and
antidepressant therapy is usually required to maintain remission.
Exercise benefits people with depression and several trials have had promising results as long as the "dose" and intensity
of the activity is adequate. Attention to compliance is important for people with depression and the successful trial
interventions were intensive and supervised.12
A review of complementary therapies for depression shows St Johns Wort, QiGong, and massage have some evidence of benefit.13 St
Johns Wort is the most studied of these; however few trials have included older people. It is important to take into consideration
potential adverse effects and interactions with conventional treatments.
A range of interventions are required to improve the quality of life for elderly people with depression
Elderly people with depression are often struggling to cope with the activities of daily living and co-morbidities or
major life events may add to the problem. Social, environmental and household support is often just as important as pharmacological
and psychological therapies in helping elderly people with depression.